FF
IART icon

FourThought Financial’s Integra LifeSciences IART Stock Holding History

FourThought Financial’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$19K Buy
452
+233
+106% +$11.9K ﹤0.01% 875
2022
Q2 		$12K Buy
+219
New +$13.2K ﹤0.01% 980

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

FourThought Financial's IART Position: Q3 2022 in Review

FourThought Financial increased its Integra LifeSciences (IART) stake by 106% in Q3 2022, buying an estimated $11.9K and bringing the position to 452 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #875.

FourThought Financial first reported a position in IART in Q2 2022 and has held it in 2 quarters since. 282 funds tracked by Wall St. Rank hold IART as of Q3 2022.

  • FourThought Financial held 452 shares of Integra LifeSciences worth $19K as of Q3 2022.
  • FourThought Financial bought 233 Integra LifeSciences shares in Q3 2022, an estimated $11.9K.
  • Integra LifeSciences made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #875 holding.
  • FourThought Financial first reported a position in Integra LifeSciences in Q2 2022 and has held it in 2 quarters since.
  • 282 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.